Newsbenzinga
Bristol Myers Says Cell Therapy Shows Promise For Heavily Pretreated Blood Cancer Patients
· Published
Article summary
Bristol Myers Squibb reported positive Phase 2 results for its arlo-cel therapy, meeting key endpoints for multiple myeloma patients.
An excerpt from the original article.
Comments —
Loading comments…